Charles Clayton Donaldson

Title: The Innovations of Charles Clayton Donaldson

Introduction

Charles Clayton Donaldson is an accomplished inventor based in Madison, WI (US). He has made significant contributions to the field of medication dosing technology, holding a total of 4 patents. His work focuses on enhancing the accuracy and efficiency of medicament delivery systems.

Latest Patents

One of Donaldson's latest patents is titled "Real time adaptive controller medication dosing." This patent describes systems and methods for monitoring accurate, real-time medicament device events. It involves performing analytics on the collected data and providing notifications based on the analysis. The application server receives controller medication events, analyzes these events along with their associated times, and characterizes them to send notifications for future doses. The controller medication dosage plan specifies a dose time for a planned dose, a narrow time window around the dose time, and an expanded time window that is longer than the narrow time window. Events are characterized based on their timing relative to the dose time and the defined time windows.

Career Highlights

Donaldson is currently associated with Reciprocal Labs Corporation, where he continues to innovate in the field of medication dosing technology. His work has the potential to significantly improve patient care by ensuring timely and accurate medication delivery.

Collaborations

Some of his notable coworkers include Christopher Hogg and Gregory F Tracy, who contribute to the collaborative environment at Reciprocal Labs Corporation.

Conclusion

Charles Clayton Donaldson's innovative work in medication dosing technology exemplifies the impact of dedicated inventors in the healthcare sector. His patents reflect a commitment to improving patient outcomes through advanced technology.